Pre-operative chemotherapy or neoadjuvant chemotherapy is a standard therapy option in locally advanced breast cancer and in cancers with triple negative or Her2 positive intrinsic subtypes [1,2,3,4,5,6,7,8]. The gene discussed is ERBB2; the disease is breast carcinoma.